Bearing in mind that DNA-hypermethylation is often a result of an imbalance of DNA methylation and demethylation which can be based on reduced TET1 protein activity as shown in gliomas, we investigated the protein levels of TET1 and TET2 via immunohistochemistry. The gene discussed is TET1; the disease is central nervous system cancer.